reverse transcriptase inhibitors


reverse transcriptase inhibitors

A range of drugs that interfere with the process by which retroviruses, such as HIV, convert their RNA genomes into duplex DNA which can then be incorporated into the DNA of the attacked cell. By delaying this process the progress of a retroviral infection can be slowed. Brand names are lamivudine, stavudine, zalcitabine and zidovudine.